# Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease

> **NCT00976690** · PHASE3 · COMPLETED · sponsor: **Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives** · enrollment: 83 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Azathioprine OR Mesalazine

## Key facts

- **NCT ID:** NCT00976690
- **Lead sponsor:** Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2010-10
- **Final completion:** 2010-12
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2011-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976690, "Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00976690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*